Gilead Sciences reported $26.22B in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
ALKERMES ALKS:US USD 293.9M 633K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 38.7B 2.18B
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Coherus Biosciences CHRS:US USD 245.25M 175.72M
Eli Lilly And LLY:US USD 15.89B 925.4M
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Glaxosmithkline GSK:US GBP 22.12B 4M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Moderna Inc MRNA:US USD 1.15B 384M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Novartis NOVN:VX USD 28.44B 2.59B
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Puma Biotechnology PBYI:US USD 97.99M 312K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 33.59M 605K